Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 22652

Known as: CGS-22652 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Microvascular degeneration is an important event in oxygen-induced retinopathy (OIR), a model of retinopathy of prematurity… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Although reductions in retinal blood flow (RBF) in response to acute hyperoxia are well described, the mechanistic basis of this… Expand
Is this relevant?
1995
1995
The goal of the study was to determine the role of cyclooxygenase metabolites in mediating platelet-induced suppression of… Expand
Is this relevant?
1994
1994
To evaluate the contribution of thromboxane (Tx) A2-prostaglandin (PG) H2 in two-kidney, one-clip Goldblatt hypertension (GH), 26… Expand
Is this relevant?
1994
1994
A quantitative analytical method for the determination of a new thromboxane synthetase inhibitor (CGS 22652) in human plasma has… Expand
Is this relevant?
1993
1993
Various antiplatelet agents were examined for their effectiveness as adjuncts to thrombolytic therapy in a canine model of… Expand
Is this relevant?
1993
1993
1. The effects of CGS 22652, a thromboxane (Tx) A2 synthase inhibitor and TxA2/prostaglandin (PG) H2 receptor antagonist, on… Expand
Is this relevant?